Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.

According to Japanese scientists, certain bacteria found in the digestive systems of frogs and lizards can completely ...

A revolutionary quantum sensing project that could transform cancer treatment by tracking how immune cells interact with tumours has been awarded a prestigious £2 million Future Leaders Fellowship.

Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, ...

Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...